Clinical Trial

Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD

Completed
View on ClinicalTrials.gov →
Summary
A study for evaluating the safety and efficacy of L. lactis CKDB001 on liver aminotransferases in subjects with nonalcoholic fatty liver disease
Trial Details
NCT Number NCT07378280
Lead Sponsor Chuncheon Sacred Heart Hospital
Collaborators: Chong Kun Dang Bio
Conditions Non Alcoholic Fatty Liver Disease
Enrollment 95 participants
Start Date 2021-08-18
Primary Completion 2023-08-02 (estimated)
Study Completion 2023-11-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-30